Chicago, USA - 30 May `19Gut and Skin Microbiome

Official Title: The Gut and Skin Microbiome in Vitiligo Disease Progression

In Brief: Investigators plan to perform a pilot study that aims to characterize the microbiome of human vitiligo patients with both active and stable disease and compare this to the microbiome of age and sex matched controls. The investigators aim to answer the question whether the gut and skin microbiome of patients with vitiligo differs from the general population.

Ages Eligible: 18 Years to 89 Years 

Start Date: May 30, 2019

Completion Date (estimated): December 2021

Status: Active, recruiting

Study ID from ClinicalTrials.gov: NCT03577327

Location: Northwestern University, Chicago, Illinois, United States, 60611

Contact: To learn more about this study, you or your doctor may contact Prof. Caroline Le Poole, by phone +1-312-503-5944 or email NUdermatologyCTU@northwestern.edu. Please refer to this study by its NCT number.

FAQOther Questions

  • What are risks of oral and topical corticosteroids?

    Corticosteroid drugs (like hydrocortisone, and others) are often used for treating vitiligo. By mimicing the effects of hormones your body produces naturally in your adrenal gla...

  • How can I explain vitiligo to my children?

    Vitiligo can be puzzling for a child because a person who has it isn't "ill" in a common sense.  To choose the right words to explain vitiligo diagnosis to a child, first consi...

  • What is vitiligo?

    Vitiligo (pronounced vit-ill-EYE-go) is a relatively common skin disease characterized by smooth, white, painless spots or patches on various parts of the body and hairs above i...